GlassScriptPhysician profile
Todd S Roth
NPI 1063622090
$10,928.80
in general payments reported to CMS, 2019-2025
6 companies · $551 in 2025
The $551 reported for 2025 was more than what 94% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165 · 2020: $165 · 2021: $1,915 · 2022: $692 · 2023: $4,829 · 2024: $2,612 · 2025: $551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000 · Consulting Fee: $2,100 · Travel and Lodging: $1,573 · Food and Beverage: $1,239 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
| Consulting Fee | $2,100.00 |
| Travel and Lodging | $1,573.26 |
| Food and Beverage | $1,238.84 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,680.12 | 2021-2025 | Harmony |
| Actelion Pharmaceuticals US, INC. | $2,692.02 | 2023-2024 | Opsumit, Uptravi |
| Abbott Laboratories | $330.08 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $135.00 | 2023 | Evkeeza |
| Ge Healthcare | $73.57 | 2021 | |
| Cmp Pharma, INC. | $18.01 | 2023 | Norliqva |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Roth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.